An analysis of the formulation of strategic alliances: a focus on the pharmaceutical industry

被引：2

作者：

Lin, BS ^{[1
]}

Darling, J

机构：

[1] Louisiana State Univ, Shreveport, LA 71105 USA

[2] Pittsburg State Univ, Pittsburg, KS 66762 USA

来源：

INDUSTRIAL MANAGEMENT & DATA SYSTEMS | 1999年 / 99卷 / 03期

关键词：

alliances; competences; contingency planning; pharmaceutical industry; regulations; uncertainty;

D O I：

10.1108/02635579910252653

中图分类号：

TP39 [计算机的应用];

学科分类号：

081203 ; 0835 ;

摘要：

Despite the increased frequency and major importance of strategic alliances in the pharmaceutical industry, little is known about the formation of these alliances, or factors by which these alliances affect the business practices. The present study centers on strategic alliances formation in the pharmaceutical industry. A contingency approach is employed to analyze the formation of strategic alliances. Finally, suggestions are made regarding the empirical research needed in order to enhance our ability to explain formation of strategic alliances in the pharmaceutical industry.

引用

页码：121 / 127

页数：7

共 50 条

[1] Analysis of the formulation of strategic alliances: A focus on the pharmaceutical industry
Louisiana State University, Shreveport, LA, United States
不详
Ind Manage Data Sys, 3 (121-127):
[2] An analysis of strategic alliances formation in the pharmaceutical industry
Lin, B
DECISION SCIENCES INSTITUTE, 1997 ANNUAL MEETING, PROCEEDINGS, VOLS 1-3, 1997, : 309 - 311
[3] Rent Appropriation in Strategic Alliances: A Study of Technical Alliances in Pharmaceutical Industry
Hughes-Morgan, Margaret
Yao, B. Emery
LONG RANGE PLANNING, 2016, 49 (02) : 186 - 195
[4] Inter-firm partnerships - strategic alliances in the pharmaceutical industry
Yoon, Jiho
Rosales, Claudia
Talluri, Srinivas
INTERNATIONAL JOURNAL OF PRODUCTION RESEARCH, 2018, 56 (1-2) : 862 - 881
[5] Market differential evaluations of strategic alliances in the pharmaceutical/biotech industry
Faculty of Business and Economics, Wilfrid Laurier University, Waterloo, Ont. N2L 3C5, Canada
J. High Technol. Manage. Res., 2006, 1 (43-52):
[6] International strategic alliances in the Iranian pharmaceutical industry: an analysis of key success and failure factors
Dadfar, Hossein
Dahlgaard, Jens J.
Brege, Staffan
Arzaghi, Bahareh Javadian
TOTAL QUALITY MANAGEMENT & BUSINESS EXCELLENCE, 2014, 25 (7-8) : 812 - 826
[7] Strategic analysis and the pharmaceutical industry
Amédée-Manesme, O
THERAPIE, 2000, 55 (02): : 313 - 317
[8] Innovative capabilities and strategic alliances: Who is gaining what in the pharmaceutical industry
Ohba, Marisa
Figueiredo, Paulo N.
Journal of Commercial Biotechnology, 2007, 13 (04) : 273 - 282
[9] WHEN ARE ASSETS COMPLEMENTARY? STAR SCIENTISTS, STRATEGIC ALLIANCES, AND INNOVATION IN THE PHARMACEUTICAL INDUSTRY
Hess, Andrew M.
Rothaermel, Frank T.
STRATEGIC MANAGEMENT JOURNAL, 2011, 32 (08) : 895 - 909
[10] STRATEGIC ANALYSIS OF THE WORLD PHARMACEUTICAL INDUSTRY
Kesic, Dragan
MANAGEMENT-JOURNAL OF CONTEMPORARY MANAGEMENT ISSUES, 2009, 14 (01) : 59 - 76

← 1 2 3 4 5 →